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Abstract. Malaria-endemic countries have implemented community health worker (CHW) programs to provide
malaria diagnosis and treatment to populations living beyond the reach of health systems. However, there is limited
evidence describing the referral practices of CHWs. We examined the impact of malaria rapid diagnostic tests
(mRDTs) on CHW referral in two cluster-randomized trials, one conducted in a moderate-to-high malaria transmission
setting and one in a low-transmission setting in Uganda, between January 2010 and July 2012. All CHWs were trained
to prescribe artemisinin-based combination therapy (ACT) for malaria and recognize signs and symptoms for referral
to health centers. CHWs in the control arm used a presumptive diagnosis for malaria based on clinical symptoms,
whereas intervention arm CHWs used mRDTs. CHWs recorded ACT prescriptions, mRDT results, and referral in
patient registers. An intention-to-treat analysis was undertaken using multivariable logistic regression. Referral was
more frequent in the intervention arm versus the control arm (moderate-to-high transmission, P < 0.001; low transmis-
sion, P < 0.001). Despite this increase, referral advice was not always given when ACTs or prereferral rectal artesunate
were prescribed: 14% prescribed rectal artesunate in the moderate-to-high setting were not referred. In addition,
CHWs considered factors alongside mRDTs when referring. Child visits during the weekends or the rainy season were
less likely to be referred, whereas visits to CHWs more distant from health centers were more likely to be referred
(low transmission only). CHWs using mRDTs and ACTs increased referral compared with CHWs using a presumptive
diagnosis. To address these concerns, referral training should be emphasized in CHW programs as they are scaled-up.
INTRODUCTION
Early diagnosis and effective treatment of malaria is an
essential strategy to reduce the high under-5 child morbidity
and mortality associated with malaria in sub-Saharan Africa
(SSA).1,2 To address the disease burden, United Nations
Children’s Fund, World Health Organization (WHO), and
Save the Children have supported SSA countries to imple-
ment national community-based programs such as integrated
community case management (iCCM) for the diagnosis and
treatment of malaria, pneumonia, and diarrhea.3,4 The pro-
grams typically train laypersons with limited medical education,
as community health workers (CHWs) that are able to provide
case management services in communities with poor access
to public health facilities.
Early community studies found CHWs were able to
reduce malaria morbidity and mortality using a presumptive
diagnosis based on clinical symptoms.5,6 However, WHO
now recommends all suspected cases of malaria should be
tested with a malaria rapid diagnostic test (mRDT) and on
confirmation, treated with an artemisinin-based combination
therapy (ACT).7 Following WHO recommendations, and sup-
ported by strong evidence that CHWs can effectively treat
uncomplicated malaria and adhere to mRDT results,8,9 many
SSA countries have begun to introduce mRDTs and ACTs
at the community level. Community programs usually also
train CHWs to refer children who present with complicated
illnesses to a health center for further management. A referral
pathway is an important element of primary health care that
ensures the continuity of a child’s care from the community to
health center. It helps to ensure that professional health-care
workers manage complex illnesses in medically equipped
health facilities, whereas CHWs manage the uncomplicated
illnesses in the community. Failure to refer or comply with
referral advice may increase the risk of medical complications.
Despite the large body of evidence on implementing and
scaling-up national CHW programs, currently there is rela-
tively little evidence on referral practices by CHWs using both
mRDTs and ACTs. Two small-scale studies in Tanzania and
Sierra Leone found CHWs referred between 5% and 15% of
children and very few children completed referral.10,11 Filling
the evidence gap on referral was identified as important
component to improve the effectiveness, implementation, and
scale-up of community-based programs by the international
taskforce on iCCM.12
We undertook an exploratory examination of referrals
made by CHWs as part of two large trials that evaluated the
impact of mRDTs on appropriately targeted ACTs: one trial
was conducted in a moderate-to-high malaria transmission
setting and the other in a low-transmission setting.13 The tri-
als provided an opportunity to yield insights on how referral
patterns can change following the introduction of mRDTs
and the objective of this referral study was to examine the
referrals made by CHWs and explore the factors associated
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with referral when CHWs diagnosed malaria using either a
presumptive or mRDT-based diagnosis.
METHODS
Study area and participants. Both trials were conducted
in Rukungiri District, Western Region, Uganda, one in a
moderate-to-high malaria transmission setting in Bwambara
subcounty (980–1,200 m above sea level), the other in a low-
transmission setting in Nyakishenyi subcounty (1,064–2,157 m
above sea level). The 2002 census for Uganda reported a
population of 28,900 in the moderate-to-high transmission
setting and 32,000 in the low-transmission setting, with more
than 85% living in rural areas in both settings.14 The main
occupation in both settings was subsistence agriculture and
the majority of the population belonged to either Bahororo
or Bakiga ethnic groups. The climate in the area is character-
istic of east African tropics with mean annual temperatures
between 16 and 25°C and a pronounced bimodal pattern of
annual rainfall with a long rainy season between September
and December and a short rainy season from March to May.
Malaria transmission is perennial with peaks in incidence
shortly after the rains.
The public health system in each transmission setting com-
prises three health centers: two are classed as public health
center IIs (HCII), which only provide outpatient and com-
munity outreach services, and the third is a health center III
(HCIII) that provides basic preventive and curative care and
supervises lower level HCIIs. HCIIIs also have services for
diagnosis, maternity care and act as the first referral cover
for the subcounty.15
Trial design. A two-arm cluster-randomized controlled
trial design was used to evaluate the primary outcome of the
main trials, to compare the effectiveness of CHWs using
mRDTs versus CHWs using a presumptive diagnosis to treat
malaria with an ACT. In each transmission setting, a series
of community meetings were held to explain the purpose of
the research and to elect three adults per village for CHW
training. All elected CHWs provided written and informed
consent to take part in the trial and in each setting villages
(clusters) were randomized in 1:1 ratio to either the interven-
tion arm (mRDT diagnosis) or control arm (presumptive
diagnosis) using Epi-Info (Centers for Disease Control and
Prevention, Atlanta, GA). In the moderate-to-high transmis-
sion setting, 63 villages were randomized (Figure 1), and in
the low-transmission setting, 64 were randomized (Figure 2).
In addition, shortly before the trials began, community sensi-
tization was carried out in both transmission settings. Key
messages included that not all fevers are malaria and a diag-
nostic test is advisable before treatment with an ACT, a
quick malaria test (mRDT) could test for malaria, and these
tests were available from CHWs in the intervention arm.
CHW intervention. In January 2010, 381 CHWs received
training (192 and 189 in the moderate-to-high- and low-
transmission settings, respectively) in the management of
febrile children during 3- to 4-day workshops. The training
was based on a manual with simplified pictorial treatment
algorithms (job aids) to help with malaria diagnosis (Supple-
mental Figure 1). The key topics included how to take a basic
clinical history, physical examination skills, and counseling
caregivers. All CHWs were also trained on how to identify
nonsevere and severe signs and symptoms, which would require
immediate referral to the nearest health center for further
management. Severe signs and symptoms included convulsions
or fits, extreme weakness, coma, loss of consciousness, and very
hot body temperature of 38.5°C or more, whereas nonsevere
signs and symptoms included wounds or burns, ear infections,
sticky or red eyes, and vomiting and diarrhea (Figure 3). Mem-
bers of the District Health Office, research staff, and health
center workers conducted the workshops. These were interac-
tive and included presentations, role-plays, demonstrations, and
supervised clinical practice at health centers.
CHWs in the intervention arm were trained to diagnose
uncomplicated malaria with an mRDT (First Response®
FIGURE 1. Trial profile for the moderate–to–high transmission setting.
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MalariaHRP2, Premier Medical Corp, Nani Daman, India)
and prescribe test-positive children with an age-dependent
dose of ACT (artemether–lumefantrine, Lumartem®, Mumbai,
India). CHWs were also trained to prescribe prereferral treat-
ment, rectal artesunate to children who visited with signs
and symptoms of severe malaria, and to refer them immedi-
ately to the nearest health center. CHWs were trained not
to prescribe ACT to children who were mRDT negative,
and to refer those who had signs and symptoms of severe
or nonsevere illnesses (Supplemental Figure 1). In contrast,
CHWs in the control arm were trained to make a presump-
tive diagnosis based on the clinical symptoms of malaria if a
child had a fever or history of fever without any other obvi-
ous causes of fever and prescribe an ACT; if there were
severe signs and symptoms of disease, they were trained to
prescribe rectal artesunate and refer them immediately to
the nearest health center (Supplemental Figure 1).
CHWs were also trained on how to manage stocks of con-
sumables such as ACTs, gloves, cotton wool, and mRDTs
(intervention arm only). They recorded basic demographic
details about the child, such as age, sex, their village of resi-
dence, and the head of household’s name on treatment
recording forms. CHWs also reported the clinical history of
the febrile illness such as the child’s temperature, how long
ago the fever started, and whether the child slept under a
net the previous night. Finally, CHWs recorded whether an
ACT or rectal artesunate was prescribed, the test result
(intervention arm only), and whether they referred the child.
In the event of a referral, CHWs were asked to classify it as
a severe or nonsevere referral and subsequently complete a
referral form and mark the signs and symptoms they identi-
fied. The research team collected treatment recording forms
and referral forms during monthly meetings (further details
of the trial and training materials are available at www
.actconsortium.org/RDThomemanagement).
Data collection. The trials in the moderate-to-high- and
low-transmission settings started in May 2010 and June 2010,
respectively. Between May/June 2010 and December 2010,
CHWs were visited by field coordinators at least once per
week to discuss concerns or difficulties in carrying out their
roles and collected CHWs treatment recording forms, refer-
ral forms, and stock cards for ACTs. From January 2011 to
the end of the trial in July 2012, this supervision of CHWs
was scaled back and limited to monthly meetings to reflect
an operational program.
To examine the patterns of referrals CHW made, we col-
lected data from the treatment recording and referral forms
for the 19-month “operational” intervention period (January
2011 to July 2012). Previous studies suggested a number of
characteristics that may influence referral patterns, these
included the child’s age, sex, net use the previous night, and
the duration of fever.16 In addition, the day of consultation
(weekday/weekend) was derived from the date of the child’s
visit and a rainy season variable was defined to coincide with
the rains that occurred in the months September–December
and March–May. Finally, global positioning system coordi-
nates were taken in the center of each village and at the
health center to measure Euclidean (straight line) distance
from the center of a village to the nearest health center.
Statistical methods. All data were double entered and veri-
fied using Microsoft Access 2007 (Microsoft Inc., Redmond,
WA). Village distances to the nearest health center were cal-
culated using ArcGIS Desktop 10.3 (ESRI, CA). All data
were analyzed using STATA version 14.1 (STATA Corpora-
tion, College Station, TX).
The primary outcome for this analysis was the proportion
of children that were referred by CHWs and a different
method of analysis was undertaken for each trial. In the
moderate-to-high transmission setting, three clusters (two con-
trol arms and one intervention arm) withdrew from the trial
after randomization and contributed no data to the analyses,
therefore, a modified intention to treat analysis was under-
taken with 30 clusters in each arm (Figure 1). In the low-
transmission setting, no clusters withdrew after randomization
FIGURE 2. Trial profile for the low-transmission setting.
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and all clusters contributed data to the primary outcome anal-
ysis, allowing an intention-to-treat analysis (Figure 2).
We present child and cluster characteristics of the study
population in each arm using descriptive statistics (propor-
tions, means). We also assessed whether there were impor-
tant differences between the arms by examining the size of
any child- or cluster-level imbalances between the study arms
after randomization. Unadjusted and adjusted analyses were
undertaken for each trial and clustering of data at the village
level was accounted for using logistic regression models with
random effects.17 To understand the etiology of referral and
identify a set of independent factors associated with referral,
all factors identified a priori were included in multivariable
models. In both the univariable and multivariable models,
the significance of factors was compared using a likelihood
ratio test.
Ethics statement. The main trial was approved by the
Uganda National Council for Science and Technology (Ref
no. HS 555) and London School of Hygiene and Tropical
Medicine Ethics Committee (Ref no. 5595). Before randomi-
zation, meetings were held with community leaders in each
village to explain the study objectives and procedures. Writ-
ten informed consent was obtained from village leaders and
CHWs to participate in the trial. At the time of visit with a
CHW, children refusing an mRDT received presumptive
treatment. The study was registered with ClinicalTrials.gov.
Identifier NCT01048801 on January 13, 2010. An indepen-
dent data safety and monitoring board reviewed the protocol
and the analytical plan.
RESULTS
Study population. During the 19-month intervention
period (January 2011 to July 2012) 18,100 child visits were
reported by CHWs in 60 villages in the moderate-to-high
transmission setting (7,501 in the control arm and 10,599 in
the intervention arm) (Figure 1). In the low-transmission set-
ting, CHWs saw 3,501 children in 64 villages; 2,404 and 1,097
in the control and intervention arms, respectively (Figure 2).
There were similarities in both transmission settings and trial
arms: the majority of children were aged between 1 and
5 years, approximately half were female, more than 86%
had slept under a net the previous night, and nearly all
(> 82.0%) resided in the same village as the CHW (Table 1).
We also examined characteristics that were different between
the arms after randomization and found a larger proportion
of children visited control arm villages within 24 hours after
the onset of fever symptoms, compared with the intervention
arm (moderate-to-high transmission setting, 94.4% versus
85.1%; low-transmission setting, 88.3% versus 78.4%; control
and intervention arms, respectively). Similarly, a greater pro-
portion of visits occurred during the rainy season in the
intervention arm villages compared with the control arm
(moderate-to-high transmission setting, 63.2% versus 56.3%;
low-transmission setting, 65.5% versus 59.7%). The notable
difference between the transmission settings was that chil-
dren in the low-transmission setting lived more than 5 km
away from the nearest public health center compared with chil-
dren in the moderate-to-high transmission setting (Table 1).
Referral and treatment practices. CHWs in the low-
transmission setting referred a greater proportion of child
visits than CHWs in the moderate-to-high transmission
setting (31.3% [1,096/3,501] versus 15.2% [2,760/18,100]).
Within each transmission setting, CHWs referred more fre-
quently in the intervention arm compared with the control
arm (moderate-to-high transmission setting, 35.3% versus
1.0%, P < 0.001; low-transmission setting, 71.3% versus
13.1%, P < 0.001; Tables 2 and 3). An examination of refer-
rals according to mRDT results in the intervention arms found
61.7% (2,558/4,147) of mRDT-negative children were referred
FIGURE 3. Severe and non-severe signs and symptoms community health workers (CHWs) were trained to identify at the time of a child visit.
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compared with 2.8% (93/3,355) of mRDT-positive children
in the moderate-to-high transmission setting (Table 2). While
in the low-transmission setting, 72.4% (770/1,064) of mRDT-
negative children were referred compared with 38.2% (13/34)
mRDT-positive children (Table 3).
CHWs ACT prescribing patterns and their referral practices
are also shown in Tables 2 and 3. Referral was more frequent
when an ACT was not prescribed compared with when an
ACT was prescribed in both settings (moderate-to-high trans-
mission setting, 61.1% versus 0.6%; low-transmission setting,
74.3% versus 9.0%). In both settings, the use of prereferral
rectal artesunate was low with less than 2% of all visits receiv-
ing rectal artesunate (0.4% [70/18,100] and 1.7% [59/3,501] in
moderate-to-high and low-transmission setting, respectively).
TABLE 2
Children referred in each arm, their mRDT test result, and ACT treatment received in the moderate-to-high transmission setting
Total visits No. referred (%) No. of nonsevere referrals (%)* No. of severe referrals (%)*
Trial arm
Control (presumptive arm) 10,599 109 (1.0) 20 (24.7) 61 (75.3)
Intervention (mRDT arm) 7,501 2,651 (35.3) 1,562 (62.6) 932 (37.4)
Within intervention arm
mRDT negative 4,147 2,558 (61.7) 1,536 (63.3) 892 (36.7)
mRDT positive 3,355 93 (2.8) 26 (39.4) 40 (60.6)
ACT prescription†
ACT not prescribed 4,039 2,495 (61.8) 1,478 (62.7) 878 (37.3)
ACT prescribed 13,785 78 (0.6) 25 (53.2) 22 (46.8)
Rectal artesunate prescribed 70 60 (85.7) 5 (9.8) 46 (90.2)
ACT = artemisinin-based combination therapy; mRDT = malaria rapid diagnostic test.
*Percentage of type of referral (severe or nonsevere) of those who were referred, 185 visits missing type (severe or nonsevere) of referral.
†206 missing ACT prescription.
TABLE 1
Characteristics of children visiting CHWs
Moderate-to-high transmission setting Low-transmission setting
Control arm Intervention arm Control arm Intervention arm
Frequency (%) Frequency (%) Frequency (%) Frequency (%)
Number of participating villages (clusters) 30 30 32 32
Number of CHWs 90 90 96 93
Total number of child visits to CHWs 10,599 7,501 2,404 1,097
Age group (years)
< 1.0 2,042 (19.4) 1,528 (20.6) 587 (24.6) 297 (27.6)
1.0–2.9 3,982 (37.7) 3,113 (41.9) 970 (40.7) 478 (44.4)
3.0–4.9 4,506 (42.7) 2,751 (37.1) 817 (34.3) 295 (27.4)
5.0–15.0 21 (0.2) 33 (0.4) 11 (0.5) 6 (0.6)
Sex
Male 5,329 (50.6) 3,907 (52.3) 1,264 (52.6) 550 (50.1)
Female 5,207 (49.4) 3,559 (47.7) 1,137 (47.3) 544 (49.6)
Slept under a net the previous night
No 919 (8.7) 738 (9.8) 222 (9.2) 145 (13.2)
Yes 9,507 (89.7) 6,687 (89.1) 2,146 (89.3) 938 (85.5)
Resident in the same village as CHW
No 785 (7.4) 690 (9.2) 311 (12.9) 191 (17.4)
Yes 9,751 (92.0) 6,792 (90.5) 2,085 (86.7) 901 (82.1)
Mean body temperature (°C) 37.43 (37.42–37.44) 37.38 (37.35–37.40) 37.42 (37.39–37.46) 37.21 (37.13–37.30)
Time of visit to CHW after onset of symptoms
> 24 hours 586 (5.6) 1,089 (14.9) 271 (11.7) 232 (21.6)
Within 24 hours 9,799 (94.4) 6,222 (85.1) 2,050 (88.3) 844 (78.4)
Day of visit to a CHW
Weekday 7,267 (68.6) 5,219 (69.6) 1,632 (67.9) 743 (67.7)
Weekend 3,332 (31.4) 2,282 (30.4) 772 (32.1) 354 (32.3)
Season of visit to a CHW
Dry 4,630 (43.7) 2,761 (36.8) 969 (40.3) 378 (34.5)
Rainy 5,969 (56.3) 4,740 (63.2) 1,435 (59.7) 719 (65.5)
Village distance to nearest health facility (km)
0.0–2.4 4,179 (39.8) 3,995 (53.7) 793 (34.6) 204 (19.8)
2.5–4.9 5,099 (48.6) 3,234 (43.5) 667 (29.1) 487 (47.3)
5.0–7.4 1,220 (11.6) 207 (2.8) 696 (30.3) 250 (24.3)
7.5–8.9 0 (0.0) 0 (0.0) 139 (6.1) 89 (8.6)
CHW = community health worker.
Data missing in the moderate-to-high-transmission setting for age 124 (48 control, 76 intervention), sex 98 (63 control, 35 intervention), slept under a net the previous night 249 (173 control,
76 intervention), resident in the same village as CHW 82 (63 control, 19 intervention), mean body temperature (°C) 267 (187 control, 80 intervention), and time of visit to CHW after onset of
symptoms 404 (214 control, 190 intervention).
Data missing in the low-transmission setting for age 40 (19 control, 21 intervention), sex 6 (3 control, 3 intervention), slept under a net the previous night 50 (36 control, 14 intervention),
resident in the same village as CHW 13 (8 control, 5 intervention), mean body temperature (°C) 26 (23 control, 3 intervention), and time of visit to CHW after onset of symptoms 104
(83 control, 21 intervention).
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Not all children receiving rectal artesunate were referred:
in the moderate-to-high transmission setting, 14.3% (10/70)
of children prescribed rectal artesunate were not referred;
in contrast, in the low-transmission setting this figure was
1.7% (1/59).
CHWs classified referrals as nonsevere or severe depending
on the signs and symptoms they identified (Tables 2 and 3).
Children visiting with severe signs and symptoms were more
common in the low-transmission setting compared with the
moderate-to-high transmission setting (11.5% versus 5.5%).
Nonsevere signs and symptoms for referrals were more likely
to be referred in intervention arm compared with control
arm (62.6% versus 24.7%, P < 0.001) in the moderate-to-high
transmission setting. There was no difference between the
trial arm and the type of referrals CHWs made in the low-
transmission setting (P = 0.120).
Referral signs and symptoms. The specific signs and symp-
toms for referring a child were collected using a referral
form separate to the treatment recording form, and Tables 4
and 5 list the signs and symptoms CHWs identified using this
referral form. On average, CHWs recorded three or more
signs and symptoms for referral on each referral form. How-
ever, it is important to note that unfortunately, despite the
number of referrals made and recorded in the treatment
recording form, CHWs returned very few referral forms to
the research team. In the moderate-to-high transmission set-
ting, only 260 (9.4%) referral forms were collected despite
CHWs reporting 2,760 referrals on the treatment recording
form, similarly in the low-transmission setting, only 204/1,096
(18.6%) forms were collected. The reason for this disparity
is unknown, though it is possible that CHWs only informed
patients verbally that additional treatment from a health
facility was advisable.
In the intervention arm of each transmission setting, the
most frequently reported nonsevere signs and symptoms
related to referral were “fever and mRDT negative,”
“vomiting/diarrhea,” and “pain when passing urine” (Table 4).
In contrast, the most frequent severe signs and symptoms
related to referral were “high fever,” “difficulty in breathing,”
and the “inability to drink or breastfeed” (Table 5). When the
signs and symptoms of referral were examined according to
mRDT test result, there were generally very few signs and
TABLE 4
Nonsevere referral signs and symptoms of children visiting CHWs
Moderate-to-high transmission setting Low-transmission setting
Control arm Intervention arm Control arm Intervention arm
Frequency (%) Frequency (%) Frequency (%) Frequency (%)
Nonsevere signs and symptoms for referral
Fever in babies less than 4 months old 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Fever that has lasted more than 7 days 0 (0.0) 16 (4.8) 1 (6.7) 3 (3.1)
Fever with measured temperature of > 37°C and mRDT negative 0 (0.0) 214 (64.3) 0 (0.0) 37 (38.1)
Vomiting and diarrhea 1 (100.0) 30 (9.0) 7 (46.7) 13 (13.4)
Blood in feces or urine 0 (0.0) 2 (0.6) 0 (0.0) 0 (0.0)
Pain when passing urine, or frequent urination 0 (0.0) 7 (2.1) 1 (6.7) 3 (3.1)
Wounds or burns 0 (0.0) 8 (2.4) 0 (0.0) 2 (2.1)
Skin abscess 0 (0.0) 3 (0.9) 0 (0.0) 0 (0.0)
Painful swellings or lumps in the skin 0 (0.0) 3 (0.9) 1 (6.7) 1 (1.0)
Ear infection (runny ear or child pulling at ear) 0 (0.0) 1 (0.3) 0 (0.0) 0 (0.0)
Sticky or red eyes 0 (0.0) 15 (4.5) 0 (0.0) 1 (1.0)
Other nonsevere signs and symptoms* 0 (0.0) 34 (10.2) 5 (33.3) 37 (38.1)
Total number of nonsevere signs and symptoms reported 1 333 15 97
Total number of nonsevere referrals forms 1 108 16 24
Mean number of signs and symptoms reported per nonsevere referral form 1.0 3.1 0.9 4.0
CHW = community health worker.
*Other nonsevere signs and symptoms in the moderate-to-high transmission setting intervention arm included cough and flu (14), difficulty in breathing (1), swollen legs and eyes (1),
headache (1), worms (1), high temperature (17), and no fever (1); other nonsevere signs and symptoms in the low-transmission setting intervention arm included cough and flu (11), difficulty in
breathing (1), high temperature (19), unable to breast feed (1), mouth wounds (1), control arm, and cough (5).
TABLE 3
Children referred in each arm, their mRDT test result, and ACT treatment received in the low-transmission setting
Total visits No. referred (%) No. of nonsevere referrals (%)* No. of severe referrals (%)*
Trial arm
Control (presumptive arm) 2,404 314 (13.1) 180 (67.7) 86 (32.3)
Intervention (mRDT arm) 1,097 782 (71.3) 444 (58.3) 317 (41.7)
Within intervention arm
mRDT negative 1,064 770 (72.4) 439 (58.4) 313 (41.6)
mRDT positive 34 13 (38.2) 5 (50.0) 5 (50.0)
ACT prescription†
ACT not prescribed 1,053 782 (74.3) 454 (59.8) 305 (40.2)
ACT prescribed 2,328 209 (9.0) 138 (79.8) 35 (20.2)
Rectal artesunate prescribed 59 58 (98.3) 12 (23.5) 39 (76.5)
ACT = artemisinin-based combination therapy; mRDT = malaria rapid diagnostic test.
*Percentage of type of referral (severe or nonsevere) of those who were referred, 69 visits missing type (severe or nonsevere) of referral.
†61 missing ACT prescription.
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symptoms recorded for mRDT-positive referrals compared
with mRDT-negative referrals, in both transmission settings
(Supplemental Tables 1 and 2).
Factors associated with referral. The results of the logistic
regression analyses to explore child factors associated with
referral are shown in Tables 6 and 7 for the moderate-
to-high and low-transmission settings, respectively. In the
adjusted analysis of both transmission settings we found
an independent relationship between ACT prescription and
referral. Children who were prescribed ACTs were very
unlikely to be referred when compared with children who
were not prescribed ACTs (moderate-to-high transmission
setting: odds ratio [OR] = 0.003; 95% confidence interval
[CI] = 0.002–0.004, P < 0.001; low-transmission setting:
OR = 0.03, 95% CI 0.01–0.05, P < 0.001). The adjusted anal-
ysis also showed CHWs in the intervention arm using mRDTs
were more than twice as likely to refer visits compared with
CHWs using a presumptive diagnosis; however, this finding
was not statistically significant (moderate-to-high transmission
setting OR = 2.07; 95% CI = 0.97–4.41; P = 0.06, low-
transmission setting OR = 2.07; 95% CI = 0.90–4.79; P = 0.09).
Associations were found in the moderate-to-high transmission
setting (Table 6), children who visited on a weekday compared
with the weekend were less likely to be referred (OR = 0.76;
95% CI = 0.65–0.89; P = 0.01), as were children who visited
during the rainy season compared with the dry season
(OR = 0.85; 95% CI = 0.73–0.99; P = 0.04). Children who
visited within 24 hours of their symptom onset were also less
likely to be referred (OR = 0.76; 95% CI = 0.61–0.94;
P = 0.01) and referral was more likely when children slept
under a net the previous night compared with children
not sleeping under a net (OR = 1.41; 95% CI = 1.08–1.85;
P = 0.011). In the low-transmission setting, the only factor
in addition to ACT prescription independently associated
with referral was distance. Children residing in villages further
away from health centers were more likely to be referred
(P = 0.001) compared with children living closer to health
centers (Table 7).
DISCUSSION
This study demonstrates that CHWs trained to use mRDTs
for malaria diagnosis refer children to health centers more fre-
quently than CHWs using a presumptive clinical diagnosis.
In both arms of the trials, CHWs were trained to refer based
on the child’s presenting signs and symptoms and thus referral
rates were expected to be similar across the two arms; how-
ever, we found the mRDT result and prescription of an ACT
affected the pattern of referral. In both transmission settings,
almost all children who were diagnosed presumptively without
an mRDT received an ACT and very few were referred. Simi-
larly, children who were mRDT positive and treated with
an ACT were rarely referred for other conditions. In contrast,
referral was more likely in mRDT-negative children, who usu-
ally did not receive an ACT. These data suggest that although
mRDT use can result in more referrals overall, the possibility
of coinfections and other illnesses may be still overlooked in
mRDT-positive children and the opportunity for early detec-
tion and referral is missed. Because the presence of referral
signs and symptoms in children and their environment is
unlikely to be affected by the method of diagnosis used by
CHWs, this suggests that use of mRDTs encourages CHWs to
consider alternative diagnoses if an ACT was not prescribed.
There were some observed differences between the two
transmission settings. Referral was more frequent in the
TABLE 5
Severe referral signs and symptoms of children visiting CHWs
Moderate-to-high transmission setting Low-transmission setting
Control arm Intervention arm Control arm Intervention arm
Frequency (%) Frequency (%) Frequency (%) Frequency (%)
Severe signs and symptoms for referral
Illness in child below 2 months 0 (0.0) 2 (0.6) 0 (0.0) 1 (1.7)
Convulsions or fits now or within the past 2 days 0 (0.0) 21 (5.9) 0 (0.0) 2 (3.4)
Coma/loss of consciousness 0 (0.0) 6 (1.7) 1 (3.0) 0 (0.0)
Patient is confused or very sleepy—cannot be woken 1 (16.7) 4 (1.1) 1 (3.0) 1 (1.7)
Extreme weakness unable to stand or sit without support 1 (16.7) 10 (2.8) 1 (3.0) 2 (3.4)
Very hot with temperature of 38.5°C or more 2 (33.3) 78 (22.0) 13 (39.4) 18 (30.5)
Very cold with temperature of 35.0°C or less 0 (0.0) 10 (2.8) 1 (3.0) 2 (3.4)
Vomiting everything—cannot keep down food or drink 0 (0.0) 36 (10.2) 3 (9.1) 5 (8.5)
Not able to drink or breastfeed 0 (0.0) 52 (14.7) 1 (3.0) 7 (11.9)
Severe anemia very pale palms, fingernails, eyelids 0 (0.0) 18 (5.1) 1 (3.0) 1 (1.7)
Yellow eyes 0 (0.0) 9 (2.5) 1 (3.0) 0 (0.0)
Difficulty in breathing 2 (33.3) 69 (19.5) 8 (24.2) 14 (23.7)
Severe dehydration 0 (0.0) 7 (2.0) 0 (0.0) 1 (1.7)
Other severe signs and symptoms‡ 0 (0.0) 32 (9.0) 2 (6.1) 5 (8.5)
Total number of severe signs and symptoms reported 6 354 33 59
Total number of severe referral forms 2 149 16 24
Mean number of signs and symptoms reported per severe referral form 3.0 2.4 2.1 2.5
Total number of severe and nonsevere signs and symptoms reported 7 687 48 156
Total nonsevere and severe referral forms* 3 257 31 78
Total referrals made 109 2,651 314 782
CHW = community health worker.
‡Other severe signs and symptoms included in the moderate-to-high transmission setting intervention arm: cough and flu (19), diarrhea (4), dysentery (2), burns (1), eye problems (2), painful
ear (3), eating problem (1), yellow skin (1), and vomiting (1); other severe signs and symptoms included in the low-transmission setting intervention arm: abdominal pain (1), constipation (1),
cough (1), difficulty in breathing (1), eye problems (1), control arm, abdominal pain (1), and eye problems (1).
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mRDT arm of the low-transmission setting compared with
the mRDT arm of the moderate-to-high transmission setting.
CHWs were trained to refer all children receiving prereferral
treatment rectal artesunate; despite this, 14% of children
receiving rectal artesunate in the moderate-to-high transmis-
sion setting were not referred. In contrast, almost all children
receiving rectal artesunate in the low-transmission setting
were referred. Poor adherence to the guidelines regarding
the use of rectal artesunate in a community-based setting is a
concern. Failure to refer children immediately to the nearest
health center for further management when they are mRDT
positive, have severe malaria signs and symptoms, and given
rectal artesunate increases the child’s risk of health complica-
tions, morbidity, and death.
The tendency of CHWs to report very few signs and symp-
toms on the referral form for children diagnosed presump-
tively or mRDT positive, compared with the greater range
reported for children who were mRDT negative, may be
partially explained by ACT prescription. Nearly all children
in these two groups (presumptive and mRDT positive)
received an ACT and CHWs may have considered the child
as treated and they may, therefore, have been less likely to
observe and record other signs and symptoms requiring
referral. In contrast, when the child is mRDT negative and
the CHW decides not to give the child an ACT, CHWs may
attempt to identify more signs and symptoms of disease. It is
also possible that children who were mRDT negative may
have presented with a more complex and obvious set of
clinical signs and symptoms compared with mRDT positive
and presumptively diagnosed children who may have only
presented with one or two discrete referral signs and symp-
toms. CHWs may increase the risk of further complications
when ACTs are prescribed to children who are mRDT posi-
tive but fail to identify other clinical symptoms requiring
referral. Unfortunately, in this study, we cannot know if
CHWs were more likely to have missed signs and symptoms
for referral in mRDT-positive children, because we did not
directly observe CHWs practice of identifying referral signs
and symptoms in these children. Nevertheless, the data
presented here are suggestive of a possible concern, and
further research, which includes observation of the clinical
encounters at community level, is needed.
Although the factors independently associated with refer-
ral differed between the two transmission settings, prescrip-
tion of an ACT was negatively associated with referral in
both settings. Indeed, once ACTs were entered into multi-
variable model, differences according to the method of
diagnosis (presumptive or mRDT) were reduced and no lon-
ger reached statistical significance. In the moderate-to-high
transmission setting, other factors associated with a lower
likelihood of referral included visits to CHWs during the
weekend compared with a weekday, and during the rainy
season compared with the dry season. These findings might
be explained by perceived barriers to accessing health care
in the area; during the weekend, health centers were often
not open nor were they staffed with health workers and
TABLE 6
ORs for referral of children in the moderate-to-high transmission setting
Variables Total visits Referrals made (%) Unadjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Study arm
Control 10,599 109 (1.0) 1 1
mRDT intervention 7,501 2,651 (35.3) 61.90 (38.40–99.77) < 0.001 2.07 (0.97–4.41) 0.060
Age group (years)
< 1.0 3,570 804 (22.5) 1 1
1.0–2.9 7,095 1,148 (16.2) 0.55 (0.48–0.62) < 0.001 0.88 (0.73–1.05)
3.0–4.9 7,257 771 (10.6) 0.31 (0.27–0.36) 0.79 (0.65–0.97) 0.140
5.0–15.0 54 10 (18.5) 0.43 (0.19–0.95) 0.68 (0.18–2.53)
Sex
Male 9,236 1,430 (15.5) 1 1
Female 8,766 1,309 (14.9) 0.93 (0.84–1.02) 0.133 0.95 (0.82–1.11) 0.528
Slept under a net the previous night
No 1,657 263 (15.9) 1 1
Yes 16,194 2,450 (15.1) 1.52 (1.27–1.83) < 0.001 1.41 (1.08–1.85) 0.011
Resident in the same village as CHW
No 1,475 310 (21.0) 1 1
Yes 16,543 2,442 (14.8) 1.03 (0.87–1.22) 0.751 0.91 (0.69–1.21) 0.531
Time of visit to CHW after onset of symptoms
> 24 hours 1,675 399 (23.8) 1 1
Within 24 hours 16,021 2,281 (14.2) 0.80 (0.69–0.92) 0.002 0.76 (0.61–0.94) 0.011
ACT prescription
No ACT 4,039 2,495 (61.8) 1 1
ACT 13,785 78 (0.6) 0.00 (0.00–0.00) < 0.001 0.00 (0.00–0.00) < 0.001
Day of visit to a CHW
Weekday 12,486 1,977 (15.8) 1 1
Weekend 5,614 783 (13.9) 0.86 (0.77–0.95) 0.005 0.76 (0.65–0.89) 0.001
Season of visit to a CHW
Dry 7,391 1,110 (15.0) 1 1
Rainy 10,709 1,650 (15.4) 0.79 (0.71–0.87) < 0.001 0.85 (0.73–0.99) 0.042
Village distance to nearest health center (km)
0.0–2.4 8,174 1,548 (18.9) 1 1
2.5–4.9 8,333 1,116 (13.4) 1.15 (0.84–1.59) 1.28 (0.81–2.03)
5.0–7.4 1,427 72 (5.0) 0.97 (0.37–2.52) 0.647 1.24 (0.44–3.49) 0.579
7.5–8.9 NA NA NA NA
ACT = artemisinin-based combination therapy; CHW = community health worker; CI = confidence interval; mRDT = malaria rapid diagnostic test; OR = odds ratio.
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during the rainy season, roads and paths may become diffi-
cult to use to access the health centers. Given these barriers,
CHWs may have been reluctant to refer. The multivariable
analysis also found some evidence that children who
presented within 24 hours of their symptoms starting were
less likely to be referred. This could indicate that CHWs
were waiting to see if the child’s signs and symptoms wors-
ened over the course of a day and only referred them after
24 hours if they worsened. Paradoxically, there was also
some evidence to suggest that sleeping under a mosquito net
the previous night increased the chance of being referred,
the reasons for which are unclear. In the low-transmission
setting, we also found the main driver of referral to be the
prescribing pattern of ACTs and the only additional factor
associated with referral was the distance of the village to the
nearest health center. CHWs living in villages further away
from public health centers were more likely to refer children
than those living in villages closer to health centers. This
observation might also have been affected by the presence
of a privately run mission hospital that was located at
the outskirts of the subcounty and further away from the
more centrally located public health facilities in the low-
transmission subcounty.
This and a number of other contextual factors differed
between transmission settings, which may partly explain the
tendency for CHWs in the low-transmission setting to refer
more frequently than CHWs in the moderate-to-high trans-
mission setting. First, the type of signs and symptoms that
children presented with may differed between the two trans-
mission settings. More children in the low-transmission
setting were reported to have signs and symptoms of severe
illness compared with children in the moderate-to-high trans-
mission setting, which may have resulted in CHWs in the
low-transmission setting referring more frequently than
CHWs in the moderate-to-high transmission. The higher fre-
quency of severe signs and symptoms in the low-transmission
setting could reflect a lack of acquired immunity to malaria
among young children living in this epidemic-prone area of
the Ugandan highlands. Second, CHWs in the moderate-
to-high transmission setting experienced a high number of
visits and through experience they may have judged that
they knew when it was safe not refer a child visit. In contrast,
CHWs in the low-transmission setting experienced substan-
tially fewer visits than CHWs in the moderate-to-high trans-
mission setting, and may have felt less confident in their
diagnostic competence and/or ability to make judgments
about when it might be safe not to refer a child. Finally, in
the low-transmission setting, CHWs were also able to refer
patients to a large privately run mission hospital, which also
coordinated a community-based health insurance scheme in
the area. The scheme may have facilitated CHWs tendency
to refer, being more confident knowing that health services
and drugs would be available and that caretakers would
comply with the referral advice.
When interpreting these findings, there are limitations that
ought to be considered. CHWs often did not report the signs
TABLE 7
ORs for referral of children in the low-transmission setting
Variables Total visits Referrals made (%) OR (95% CI) P value Adjusted OR (95% CI) P value
Study arm
Control 2,404 314 (13.1) 1 1
mRDT intervention 1,097 782 (71.3) 28.45 (15.41–52.49) < 0.001 2.07 (0.90–4.79) 0.090
Age group (years)
< 1.0 884 313 (35.4) 1 1
1.0–2.9 1,448 467 (32.3) 0.75 (0.59–0.95) 0.002 0.90 (0.68–1.20)
3.0–4.9 1,112 291 (26.2) 0.64 (0.49–0.83) 0.74 (0.54–1.01) 0.285
5.0–15.0 17 9 (52.9) 2.23 (0.61–8.15) 0.74 (0.13–4.32)
Sex
Male 1,814 564 (31.1) 1 1
Female 1,681 527 (31.4) 0.93 (0.77–1.13) 0.463 0.94 (0.74–1.18) 0.579
Slept under a net the previous night
No 367 124 (33.8) 1 1
Yes 3,084 951 (30.8) 1.04 (0.76–1.43) 0.788 1.12 (0.77–1.64) 0.552
Resident in the same village as CHW
No 502 177 (35.3) 1 1
Yes 2,986 916 (30.7) 1.11 (0.85–1.47) 0.440 1.19 (0.81–1.73) 0.372
Time of presentation to CHW after onset of symptoms
> 24 hours 503 212 (42.1) 1 1
Within 24 hours 2,894 851 (29.4) 0.83 (0.63–1.09) 0.180 0.89 (0.64–1.22) 0.464
ACT prescription
No ACT 1,053 782 (74.3) 1 1
ACT 2,328 209 (9.0) 0.02 (0.01–0.03) < 0.001 0.03 (0.02–0.05) < 0.001
Day of visit to a CHW
Weekday 2,375 763 (32.1) 1 1
Weekend 1,126 333 (29.6) 0.82 (0.67–1.01) 0.058 0.88 (0.69–1.13) 0.321
Season of visit to a CHW
Dry 1,347 403 (29.9) 1 1
Rainy 2,154 693 (32.2) 1.01 (0.82–1.23) 0.960 0.98 (0.77–1.25) 0.859
Village distance to nearest health center (km)
0.0–2.4 997 285 (28.6) 1 1
2.5–4.9 1,154 384 (33.3) 0.75 (0.34–1.66) 0.42 (0.21–0.83)
5.0–7.4 946 236 (24.9) 1.36 (0.52–3.58) 0.111 0.98 (0.46–2.12) 0.001
7.5–8.9 228 124 (54.4) 3.66 (0.88–15.19) 3.23 (1.01–10.38)
ACT = artemisinin-based combination therapy; CHW = community health worker; CI = confidence interval; mRDT = malaria rapid diagnostic test; OR = odds ratio.
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and symptoms for referral and very few referral forms were
collected from CHWs compared with the treatment record-
ing forms. CHWs reported child characteristics, fever history,
treatment, and referral decisions (including whether it was a
severe or nonsevere referral) on the treatment recording
forms, whereas the referral forms captured the specific signs
and symptoms for referral and were given to the caretaker
to take to the health center. There is no obvious reason why
very few referral forms were completed by CHWs, but some
qualitative evidence from comments recorded by CHWs on
the treatment forms suggests caretakers often refused refer-
ral forms and did not want to be referred to health centers.
It is thus possible that CHWs only informed patients verbally
that additional treatment from a health facility was advisable.
Therefore, the data on referral signs and symptoms recorded
on the forms may not be representative of all children who
were referred by CHWs. Finally, in this analysis, we did not
examine whether CHWs made the appropriate decision to
refer. An analysis of referral in children with measured tem-
perature ≥ 38.5°C (an eligibility criterion for severe referral)
in this study suggests that CHW adherence to referral guide-
lines was poor and CHWs failed to refer children who were
eligible for referral (Lal S, and others, 2016 Malaria Journal
in press). Therefore, the combination of underreporting of
referrals and failure to refer children who were eligible for
referral may underestimate the true number of children who
should have been referred. In addition to the data reporting
practices by CHWs, there were also differences in the sta-
tistical analyses of each trial. In the moderate-to-high
transmission setting, a modified intention to treat analysis
was undertaken because after randomization, three of the
63 clusters (9/189 CHWs) withdrew from the study and did
not provide data for the final analysis. Postrandomization
withdrawal of clusters that were not included in the analysis
may bias the results because CHWs in the clusters that with-
drew from the study may have differed from those that did
not withdraw. Therefore, some of the differences in referrals
CHWs made between the two arms may not have been due
to the intervention, but due to the differences between
CHWs in each trial that remained in the study. However,
in low-transmission setting trial, CHWs in all clusters con-
tributed data to the primary outcome and an intention-to-
treat analysis was used. Because of the different analytical
approaches used, findings from the trial in the moderate-to-
high transmission setting may not be directly comparable with
the findings from the low-transmission trial. Although this
study had limitations, similar patterns of referral and a strong
relationship between prescription of ACT and referral were
observed in both trials.
Despite the limitations, these results are consistent with pre-
vious studies that compared referral practices from CHWs
trained to use either an mRDT or a presumptive diagnosis
for malaria. A randomized crossover trial in Tanzania found
CHWs trained to use mRDTs were more than four times
more likely to refer children compared with CHWs trained to
use a presumptive diagnosis.11 However, this previous study
did not report whether the proportion of referrals differed by
mRDT-positive or -negative results. Our results were also con-
sistent with a study in Sierra Leone that found referral was
more common among mRDT-negative patients compared
with mRDT-positive children.10 Our study expands on these
previous works by describing CHWs referral patterns over a
larger time span, in two contrasting malaria-transmission set-
tings and exploring other factors in addition to the diagnosis
method that might affect the CHW’s decision to refer.
These trials were designed and conducted before iCCM
became national policy for many SSA countries and the
training in this study related to malaria, thus all the findings
may not be generalizable to iCCM programs, which also
include the management of pneumonia and diarrhea in addi-
tion to malaria. However, there are a number of referral
findings presented here that are of direct relevance to iCCM
programs. First, routinely available data can be used to mon-
itor and evaluate CHWs referral practices. Second, CHW
training packages should emphasize the provision of referral
advice to all children upon the identification of signs and
symptoms requiring referral, and finally, training should
strongly state that all children prescribed rectal artesunate
should be referred for further management. Referral pat-
terns and the reasons CHWs take to refer children should be
examined in further studies along with the health outcomes
of children referred.
CONCLUSION
During the course of 2 years, we observed low referral
rates in two contrasting malaria-transmission settings, but
training CHWs to use mRDTs and ACTs increased the refer-
ral of children compared with CHWs trained to use a pre-
sumptive clinical diagnosis for malaria. Despite the increase,
referral advice was not always given when rectal artesunate
was prescribed as a prereferral treatment. We also found
CHWs considered other factors alongside mRDTs and ACTs
when considering to give referral advice. These findings sug-
gest training on referral should be emphasized in iCCM pro-
grams being scaled-up in SSA and that additional research
is required to examine whether CHWs referral decision-
making is appropriate as well as the final health outcomes of
referred children.
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